ITeos Therapeutics Inc logo

ITeos Therapeutics Inc

1
NAS:ITOS (USA)   Ordinary Shares
$ 7.47 +0.12 (+1.63%) 01:00 PM EST
At Loss
P/B:
0.43
Market Cap:
$ 268.52M
Enterprise V:
$ -212.83M
Volume:
152.09K
Avg Vol (2M):
573.70K
Trade In:
Volume:
152.09K
At Loss
Avg Vol (2M):
573.70K

Business Description

ITeos Therapeutics Inc logo
ITeos Therapeutics Inc
NAICS : 541714 SIC : 2833
ISIN : US46565G1040

Share Class Description:

ITOS: Ordinary Shares
Description
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 88.41
Equity-to-Asset 0.87
Debt-to-Equity 0.01
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.22
Distress
Grey
Safe
Beneish M-Score 8.67
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.78
9-Day RSI 32.11
14-Day RSI 34.02
6-1 Month Momentum % -43.78
12-1 Month Momentum % -23.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.8
Quick Ratio 14.8
Cash Ratio 13.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.7
Shareholder Yield % -0.21

Financials (Next Earnings Date:2025-03-06 Est.)

ITOS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ITOS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ITeos Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 35
EPS (TTM) ($) -3.15
Beta 1.22
Volatility % 87.64
14-Day RSI 34.02
14-Day ATR ($) 0.414249
20-Day SMA ($) 8.00925
12-1 Month Momentum % -23.67
52-Week Range ($) 7.09 - 18.75
Shares Outstanding (Mil) 36.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ITeos Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

ITeos Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ITeos Therapeutics Inc Frequently Asked Questions

What is ITeos Therapeutics Inc(ITOS)'s stock price today?
The current price of ITOS is $7.47. The 52 week high of ITOS is $18.75 and 52 week low is $7.09.
When is next earnings date of ITeos Therapeutics Inc(ITOS)?
The next earnings date of ITeos Therapeutics Inc(ITOS) is 2025-03-06 Est..
Does ITeos Therapeutics Inc(ITOS) pay dividends? If so, how much?
ITeos Therapeutics Inc(ITOS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1